Drug intelligence / Profile preview

TRICARDIA

Development stage
Unknown
Lead developer
MMeditech
Modality
Small Molecules
Administration
Oral
01

Overview

TRICARDIA is an over-the-counter dietary supplement developed and marketed by MMeditech (Meditec). It is formulated as a combination of three essential B-vitamins: folic acid (Vitamin B9), pyridoxine (Vitamin B6), and cyanocobalamin (Vitamin B12). The product is primarily indicated for the management of hyperhomocysteinemia and the promotion of cardiovascular health. Elevated levels of homocysteine are a recognized risk factor for the development of atherosclerosis, coronary heart disease, and stroke. TRICARDIA works by providing the necessary enzymatic cofactors for the remethylation and transsulfuration pathways, which convert homocysteine into methionine and cysteine, respectively, thereby lowering its concentration in the blood.

Brand names
TRICARDIA
Other names
Tricardia
02

Targets

MTR (Methionine synthase)CBS (Cystathionine beta-synthase)

Beyond the preview

Go deeper on TRICARDIA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRICARDIA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call